Contrary to the drastic down-regulation of survivin in SK-MEL-2 and other tumor cell lines induced by ASK, this treatment reduced the expression of survivin by only 30% compared with the control ASO-C (Fig. 6f). The gene discussed is BIRC5; the disease is neoplasm.